“Scenesse is and will be, in my view, one of the most important pharmaceutical innovations of our time.”
”Our time”? ……… or our great grandchildren’s time ? …… Or never with this guy in control!
Applying minimal effort and condemning the company to the go slow lane, stupidly hoping that authoritys will do a 180 on skin tanning and sunlight exposure in 2029 (maybe!) is a joke but seems obvious (for around a decade now to me at least) that this lazy and weak approach is way more beneficial to Wolgen, in the end! ……. I’m confident that progress will remain frustratingly glacial under his management.
Australia's Greatest Biotech, page-5
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.73 |
Change
0.120(0.88%) |
Mkt cap ! $687.3M | |||
| Open | High | Low | Value | Volume |
| $13.55 | $13.90 | $13.54 | $835.5K | 61.00K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 312 | $13.68 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.76 | 226 | 1 |
View Market Depth
| Last trade - 16.10pm 05/11/2024 (20 minute delay) ? |
| CUV (ASX) Chart |